Research ArticleTheranostics
Dissimilar DNA Damage to Blood Lymphocytes After 177Lu-Labeled DOTATOC or Prostate-Specific Membrane Antigen Therapy
Philipp Ritt, Camille Jobic, Michael Beck, Christian Schmidkonz, Torsten Kuwert, Michael Uder and Michael Brand
Journal of Nuclear Medicine March 2021, 62 (3) 379-385; DOI: https://doi.org/10.2967/jnumed.120.243782
Philipp Ritt
1Clinic of Nuclear Medicine, University Hospital Erlangen, Erlangen Germany; and
Camille Jobic
1Clinic of Nuclear Medicine, University Hospital Erlangen, Erlangen Germany; and
Michael Beck
1Clinic of Nuclear Medicine, University Hospital Erlangen, Erlangen Germany; and
Christian Schmidkonz
1Clinic of Nuclear Medicine, University Hospital Erlangen, Erlangen Germany; and
Torsten Kuwert
1Clinic of Nuclear Medicine, University Hospital Erlangen, Erlangen Germany; and
Michael Uder
2Department of Radiology, University Hospital Erlangen, Erlangen, Germany
Michael Brand
2Department of Radiology, University Hospital Erlangen, Erlangen, Germany

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 3
March 1, 2021
Dissimilar DNA Damage to Blood Lymphocytes After 177Lu-Labeled DOTATOC or Prostate-Specific Membrane Antigen Therapy
Philipp Ritt, Camille Jobic, Michael Beck, Christian Schmidkonz, Torsten Kuwert, Michael Uder, Michael Brand
Journal of Nuclear Medicine Mar 2021, 62 (3) 379-385; DOI: 10.2967/jnumed.120.243782
Dissimilar DNA Damage to Blood Lymphocytes After 177Lu-Labeled DOTATOC or Prostate-Specific Membrane Antigen Therapy
Philipp Ritt, Camille Jobic, Michael Beck, Christian Schmidkonz, Torsten Kuwert, Michael Uder, Michael Brand
Journal of Nuclear Medicine Mar 2021, 62 (3) 379-385; DOI: 10.2967/jnumed.120.243782
Jump to section
Related Articles
Cited By...
- No citing articles found.